3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow bremelanotide: new trials by email Literature Review of bremelanotide trials Research Report on bremelanotide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 3, Bridging, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate the Efficacy and Safety of Subcutaneously Administered Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder (With or Without Decreased Arousal) Bremelanotide, Placebo - Hypoactive Sexual Desire Disorder | Phase 3 | Completed | Kwang Dong Pharmaceutical co., ltd. | 193 | 2021-05-10 | 2024-11-13 |
| 2. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder Bremelanotide, Placebo - Hypoactive Sexual Desire Disorder | Phase 3 | Completed | Palatin Technologies, Inc | 714 | 2015-01-01 | 2021-01-28 |
| 1. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder Bremelanotide, Placebo - Hypoactive Sexual Desire Disorder | Phase 3 | Completed | Palatin Technologies, Inc | 723 | 2014-12-01 | 2021-04-09 |
Sexual Dysfunctions, Psychological (3)
Palatin Technologies, Inc (2) · Kwang Dong Pharmaceutical co., ltd. (1)
Canada (2) · United States (2) · South Korea (1)
Robert Jordan (2) · Soo Woong Kim, Dr (1) · Tak Kim, Dr (1)
PMID 10782451, PMID 28189361, PMID 31599840, PMID 31599847, PMID 33033885, PMID 33538638, PMID 35147466, PMID 36809187